COVID19 vaccine: Bharat Biotech to submit revised Phase 3 clinical trial protocol to DCGI soon
India’s Bharat Biotech will be submitting the Phase 3 clinical trial to the drugs controller general of India (DCGI) for its anti-coronavirus disease (Covid-19) vaccine...
